HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism.

Abstract
Obesity is a multi-systemic disorder of energy balance. Despite intense investigation, the determinants of energy homeostasis remain incompletely understood, and efficacious treatments against obesity and its complications are lacking. Here, we demonstrate that conferred arginine iminohydrolysis by the bacterial virulence factor and arginine deiminase, arcA, promotes mammalian energy expenditure and insulin sensitivity and reverses dyslipidemia, hepatic steatosis, and inflammation in obese mice. Extending this, pharmacological arginine catabolism via pegylated arginine deiminase (ADI-PEG 20) recapitulates these metabolic effects in dietary and genetically obese models. These effects require hepatic and whole-body expression of the autophagy complex protein BECN1 and hepatocyte-specific FGF21 secretion. Single-cell ATAC sequencing further reveals BECN1-dependent hepatocyte chromatin accessibility changes in response to ADI-PEG 20. The data thus reveal an unexpected therapeutic utility for arginine catabolism in modulating energy metabolism by activating systemic autophagy, which is now exploitable through readily available pharmacotherapy.
AuthorsYiming Zhang, Cassandra B Higgins, Brian A Van Tine, John S Bomalaski, Brian J DeBosch
JournalCell reports. Medicine (Cell Rep Med) Vol. 3 Issue 1 Pg. 100498 (01 18 2022) ISSN: 2666-3791 [Electronic] United States
PMID35106510 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 The Author(s).
Chemical References
  • Beclin-1
  • fibroblast growth factor 21
  • Polyethylene Glycols
  • Fibroblast Growth Factors
  • Arginine
  • Hydrolases
  • ADI PEG20
  • arginine deiminase
  • Glucose
Topics
  • Animals
  • Arginine (metabolism)
  • Autophagy
  • Beclin-1 (metabolism)
  • Dependovirus (metabolism)
  • Diabetes Mellitus, Experimental (genetics, pathology)
  • Diet, Western
  • Dyslipidemias (pathology)
  • Energy Metabolism
  • Fatty Liver (pathology)
  • Fibroblast Growth Factors (metabolism)
  • Glucose (metabolism)
  • Hepatocytes (metabolism)
  • Homeostasis
  • Hydrolases (chemistry, metabolism)
  • Insulin Resistance
  • Liver (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Polyethylene Glycols (chemistry)
  • Thermogenesis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: